Abstract
Breast cancer (BC) and gynecological cancers have emerged as significant threats to women’s health and are known to be among the primary causes of cancer-related fatalities in women. Innovative treatments and early detection may significantly cut mortality rates for these diseases. In this study, potential hub genes were thoroughly evaluated in the contexts of BC, ovarian cancer (OC), and endometrial cancer (EC). Initially, a total of 374 overlapping differentially expressed genes (DEGs) were identified within the microarray datasets. The STRING database and Cytoscape software analyzed protein-protein interaction (PPI) network structure, whereas FunRich found hub genes. The five hub genes that were ultimately discovered are PTEN, SMAD2, FASN, CYCS, and KRAS. As a result, these genes may serve as potential biomarkers for the aforementioned diseases. Importantly, this study offers valuable insights into all three diseases based on recent molecular advancements. However, further investigation is required to precisely measure these biomarkers’ effectiveness.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Frontiers in Life Sciences and Related Technologies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
